Login / Signup

Viewpoint Paper: Tiering Drug-Drug Interaction Alerts by Severity Increases Compliance Rates.

Marilyn D. PaternoSaverio M. MavigliaPaul N. GormanDiane L. SegerEileen YoshidaAndrew C. SegerDavid W. BatesTejal K. Gandhi
Published in: J. Am. Medical Informatics Assoc. (2009)
Keyphrases
  • viewpoint
  • drug discovery
  • pharmaceutical industry
  • clinical trials
  • drug design
  • neural network
  • case study
  • face recognition
  • object recognition
  • user interaction
  • chemical compounds
  • virtual screening